terfenadine has been researched along with Staphylococcal Infections in 2 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elsebaei, MM | 1 |
| Mohammad, H | 1 |
| Abouf, M | 1 |
| Abutaleb, NS | 2 |
| Hegazy, YA | 1 |
| Ghiaty, A | 1 |
| Chen, L | 1 |
| Zhang, J | 1 |
| Malwal, SR | 1 |
| Oldfield, E | 1 |
| Seleem, MN | 2 |
| Mayhoub, AS | 2 |
| Shahin, IG | 1 |
| Alhashimi, M | 1 |
| Kassab, AE | 1 |
| Mohamed, KO | 1 |
| Taher, AT | 1 |
2 other studies available for terfenadine and Staphylococcal Infections
| Article | Year |
|---|---|
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Alkynes; Animals; Anti-Bacterial Agents; Half-Life; Methicillin-Resistant Staphylococcus aureus; Mic | 2018 |
Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; | 2020 |